3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
50
Recurrence
6
Myelodysplastic Syndromes
4
Neoplasms
2
Leukemia, Myeloid
2
Leukemia
2
Hematologic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Myeloma
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Infections
1
Disease
1
Blast Crisis
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
5
Ciprofloxacin
4
gamma-Globulins
3
Caspofungin
3
Amoxicillin-Potassium Clavulanate Combination
3
liposomal amphotericin B
2
Voriconazole
2
Polymerase Chain Reaction
2
Pentetic Acid
2
Moxifloxacin
2
Levofloxacin
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Fluconazole
2
talquetamab
1
idecabtagene vicleucel
1
gilteritinib
1
fludarabine phosphate
1
ethanolamine oleate
1
drotrecogin alfa activated
1
amphotericin B, deoxycholate drug combination
1
X-Rays
1
Whole-Body Irradiation
1
Watchful Waiting
1
Vancomycin
1
Valacyclovir
1
Trimethoprim
1
Therapeutics
1
Tazobactam
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
gilteritinib
×
Other hematologic neoplasm
×
Clear all
NCT05791890
2023-03-30
GilteRInf
University of Rome Tor Vergata
Unknown
78 enrolled